Skip to main content

Paired Ends: Richard Lussier, Stephen Quake


CLC Bio has appointed Richard Lussier as director of business in the Americas region. He joins CLC Bio from RainDance Technologies, where he was vice president of worldwide sales. He has also held positions at Solexa (now Illumina), Fluidigm, Applied Biosystems (now Life Technologies), and Celera Genomics (now Quest Diagnostics).

Stephen Quake has won the $500,000 Lemelson-MIT prize for outstanding innovators for his work in drug discovery, genome analysis, and personalized medicine

Quake has co-founded a number of companies based on technology he has developed in his lab, including Fluidigm, Quantical Pharmaceuticals, and ImmuMetrix. He also helped develop the single-molecule sequencing technology that was commercialized by Helicos BioSciences, and the fetal DNA sequencing techniques commercialized by Verinata Health.

He is a professor of bioengineering and applied physics at Stanford University. He holds a BS and MS in mathematics from Stanford and a PhD in physics from the University of Oxford.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.